20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
The ADA Amendments Act of 2008 substantially expanded the definition of protected disabled persons u...
Read More >
Tsatsi v College of Physicians and Surgeons of Saskatchewan, 2018 SKCA 53, held that a physician’s ...
Read More >
Wilson Sonsini Goodrich & Rosati (Wilson Sonsini) is pleased to present its 2019 Antitrust Year in R...
Read More >
Refinancing activity has proven an attractive option amid COVID-19 disruption, with borrowers in goo...
Read More >
For law bloggers, if there’s one thing more satisfying than writing about an important new court de...
Read More >
Earlier this year, the New Jersey Appellate Division addressed the relationship between the Compassi...
Read More >